Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis
Abstract Objective The aim of this study is to explore the efficacy and safety of chemotherapy (CT) as a monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer. Methods A retrospective analysis was conducted on the medica...
Saved in:
Main Authors: | Bei Dong (Author), Su-Fang Zhou (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Treatment for Cervical Cancer Stage IB2 and IIA2; Radical Hysterectomy and Definitive Radiotherapy
by: Teeraphong Narukon, et al.
Published: (2010) -
Recurrence-Free Survival Stage IB1-IIA2 Intermediate Risk Group (Based on Kartu Delgado) Cervical Carcinoma after Radical Surgery and Adjuvant Radiotherapy
by: Andi Friadi, et al.
Published: (2014) -
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers
by: Aysun ALCI, et al.
Published: (2024) -
Current management of stage IB2 and bulky IIA, locally advanced, and recurrent cervical carcinoma
by: Karen K. Lo, et al.
Published: (2011) -
Caspase-3 can not be Used to Predict the Response to Neoadjuvant Chemotherapy Regiment PVB in Cervical Cancer Stage IB-IIA
by: Ediwibowo Ambari, et al.
Published: (2013)